Unlock stock picks and a broker-level newsfeed that powers Wall Street.
60.70
-4.90
(-7.47%)
At close: 4:00:02 PM EDT
60.70
0.00
(0.00%)
After hours: 4:05:14 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 14 | 12 |
| Avg. Estimate | -0.76 | -0.79 | -3.1 | -2.55 |
| Low Estimate | -1.09 | -1.14 | -4.39 | -5.01 |
| High Estimate | -0.63 | -0.64 | -1.87 | 1.53 |
| Year Ago EPS | -0.14 | -0.51 | -2 | -3.1 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 17 | 15 |
| Avg. Estimate | 19.36M | 19.33M | 88.18M | 185.72M |
| Low Estimate | 14.9M | 14.9M | 20M | 80.9M |
| High Estimate | 26M | 26M | 143M | 309.72M |
| Year Ago Sales | 39.26M | 27.38M | 107.94M | 88.18M |
| Sales Growth (year/est) | -50.69% | -29.42% | -18.31% | 110.62% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.46 | -0.5 | -0.24 | -0.47 |
| EPS Actual | -0.14 | -0.51 | -0.48 | -0.87 |
| Difference | 0.32 | -0.01 | -0.24 | -0.4 |
| Surprise % | 69.51% | -1.96% | -96.20% | -83.40% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.76 | -0.79 | -3.1 | -2.55 |
| 7 Days Ago | -0.76 | -0.79 | -3.1 | -2.55 |
| 30 Days Ago | -0.7 | -0.76 | -2.24 | -2.93 |
| 60 Days Ago | -0.7 | -0.76 | -2.24 | -2.93 |
| 90 Days Ago | -0.7 | -0.76 | -2.24 | -2.93 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | -- | -- |
| Up Last 30 Days | 2 | 2 | 2 | 3 |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 1 | 1 | 11 | 4 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ACLX | -444.14% | -54.84% | -54.91% | 17.79% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | UBS: Buy to Buy | 12/10/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/10/2024 |
| Reiterates | Needham: Buy to Buy | 12/10/2024 |
| Reiterates | Needham: Buy to Buy | 12/9/2024 |
| Maintains | Truist Securities: Buy to Buy | 11/12/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/8/2024 |
Related Tickers
NUVL Nuvalent, Inc.
68.00
-4.12%
APGE Apogee Therapeutics, Inc.
35.61
-4.68%
MLTX MoonLake Immunotherapeutics
36.35
-6.96%
MRUS Merus N.V.
39.60
-5.92%
LEGN Legend Biotech Corporation
31.52
-7.10%
KYMR Kymera Therapeutics, Inc.
25.24
-7.80%
AKRO Akero Therapeutics, Inc.
38.64
-4.55%
RVMD Revolution Medicines, Inc.
33.62
-4.92%
CNTA Centessa Pharmaceuticals plc
13.23
-8.00%
JANX Janux Therapeutics, Inc.
26.81
-0.70%